{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:54:04Z","timestamp":1761512044229},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ijantimicag.2004.08.017","type":"journal-article","created":{"date-parts":[[2005,1,4]],"date-time":"2005-01-04T12:16:53Z","timestamp":1104841013000},"page":"163-167","source":"Crossref","is-referenced-by-count":11,"title":["In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Alkorta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"P\u00e9rez-Trallero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.08.017_bib1","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/AAC.45.12.3334-3340.2001","article-title":"Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998\u20131999) multicenter surveillance study in Spain","volume":"45","author":"Perez-Trallero","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s100960050446","article-title":"In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin","volume":"19","author":"Fuentes","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib3","series-title":"Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"180","article-title":"In vitro activities of 10 fluoroquinolones against clinical isolates of Streptococcus pneumoniae during 1999 and 2000 in Gipuzkoa, Spain","author":"Perez-Trallero","year":"2001"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000048551","article-title":"Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae","volume":"47","author":"Joyanes","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0924-8579(01)00392-2","article-title":"Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers","volume":"18","author":"Prieto","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0924-8579(03)00059-1","article-title":"Efficacy and pharmacodynamics of a human like gemifloxacin versus levofloxacin treatments on guinea pigs experimental pneumonia induced by Streptococcus pneumoniae strains with decreased ciprofloxacin susceptibilities","volume":"21","author":"Garcia-Olmos","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib7","series-title":"Performance standards for antimicrobial susceptibility testing\u201412th Informational Supplement, M100-S12","year":"2002"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib8","series-title":"The quinolones","first-page":"169","article-title":"Pharmacokinetics and pharmacodynamics of the fluoroquinolones","author":"Kim","year":"2000"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF01967510","article-title":"Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin","volume":"9","author":"Perez-Trallero","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib12","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib13","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved Standard M7-A4","year":"1997"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib14","series-title":"Methods for determining bactericidal activity for antimicrobial agents, Document M26-T","year":"1992"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib15","unstructured":"European Community. Journal officiel des communaut\u00e9s europ\u00e9ennes, 18 d\u00e9cembre. Report L358. Luxembourg: Office des publications officielles des communaut\u00e9s europ\u00e9ennes; 1986."},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jac\/47.5.681","article-title":"Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens","volume":"47","author":"Garcia-Garrote","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl D","key":"10.1016\/j.ijantimicag.2004.08.017_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/31.suppl_D.137","article-title":"Medical relevance of low concentrations of antibiotics","volume":"31","author":"Lorian","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.017_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dkf131","article-title":"Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones","volume":"50","author":"Croisier","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904004066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904004066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T12:55:23Z","timestamp":1548852923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904004066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0924857904004066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.08.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}